Saltar al contenido
Merck

GF21723993

Platinum

tube, 500mm, outside diameter 1.0mm, inside diameter 0.8mm, wall thickness 0.1mm, as drawn, 99.95%

Sinónimos:

Platinum, PT007200

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Fórmula empírica (notación de Hill):
Pt
Número de CAS:
Peso molecular:
195.08
Número MDL:
Código UNSPSC:
12141734
ID de la sustancia en PubChem:
NACRES:
NA.23

Análisis

99.95%

formulario

tubes

fabricante / nombre comercial

Goodfellow 217-239-93

resistividad

10.6 μΩ-cm, 20°C

L × grosor de la pared

500 mm × 0.1 mm

D.E. × D.I.

1.0 mm × 0.8 mm

bp

3827 °C (lit.)

mp

1772 °C (lit.)

densidad

21.45 g/cm3 (lit.)

cadena SMILES

[Pt]

InChI

1S/Pt

Clave InChI

BASFCYQUMIYNBI-UHFFFAOYSA-N

Descripción general

For updated SDS information please visit www.goodfellow.com.

Información legal

Product of Goodfellow

Código de clase de almacenamiento

13 - Non Combustible Solids

Clase de riesgo para el agua (WGK)

nwg

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

Lo sentimos, en este momento no disponemos de COAs para este producto en línea.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Jianbo Wu et al.
Accounts of chemical research, 46(8), 1848-1857 (2013-07-03)
An efficient oxygen reduction reaction (ORR) offers the potential for clean energy generation in low-temperature, proton-exchange membrane fuel cells running on hydrogen fuel and air. In the past several years, researchers have developed high-performance electrocatalysts for the ORR to address
Yanlong Yang et al.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35(4), 2905-2921 (2013-12-18)
The relationship between the ERCC1/2 single nucleotide polymorphisms (SNPs) and the clinical outcomes of the platinum-based chemotherapy in the non-small cell lung cancer (NSCLC) is still inconsistent and inconclusive despite extensive investigations have been conducted to address this question. In
Yanqin Cao et al.
Journal of nanoscience and nanotechnology, 14(2), 1194-1208 (2014-04-23)
Porous platinum, that has outstanding catalytic and electrical properties and superior resistant characteristics to corrosion, has been widely applied in chemical, petrochemical, pharmaceutical, electronic, and automotive industries. As the catalytic activity and selectivity depend on the size, shape and structure
Johnson J Liu et al.
Current cancer drug targets, 12(8), 962-986 (2012-07-17)
Membrane transporters govern the movement of drugs and their metabolites across biological membranes, thereby determining their pharmacokinetics, efficacy and adverse drug reactions. Platinum-based anticancer drugs are a mainstay of chemotherapy for many human malignancies. However, their clinical utility is limited
Dalian Ding et al.
Anatomical record (Hoboken, N.J. : 2007), 295(11), 1851-1867 (2012-10-10)
Cisplatin, carboplatin, nedaplatin, and oxaliplatin are widely used in contemporary oncology; however, their ototoxic and neurotoxic side effects are quite different as discussed in this review. Cisplatin is considered the most ototoxic, but despite its reputation, the magnitude of hair

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico